Cargando…

Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin

Background Isotretinoin is the most effective treatment for moderate to severe acne. However, isotretinoin has many side effects related to its use. Since 1983, when Hetzen reported the first occurrence of new depressive symptoms in patients treated with isotretinoin, a lot of controversies emerged...

Descripción completa

Detalles Bibliográficos
Autores principales: Algamdi, Bader N, ALdahlan, Hussam W, ALALhareth, Hussain, Alghamdi, Radhwan, Alkhouzaie, Moath T, ALahmari, Nawaf, Alhudaifi, Abdulrahman, Alkasih, Yaser, Elyahia, Wyle, ALghamdi, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751261/
https://www.ncbi.nlm.nih.gov/pubmed/33364137
http://dx.doi.org/10.7759/cureus.12126
_version_ 1783625634642132992
author Algamdi, Bader N
ALdahlan, Hussam W
ALALhareth, Hussain
Alghamdi, Radhwan
Alkhouzaie, Moath T
ALahmari, Nawaf
Alhudaifi, Abdulrahman
Alkasih, Yaser
Elyahia, Wyle
ALghamdi, Khalid
author_facet Algamdi, Bader N
ALdahlan, Hussam W
ALALhareth, Hussain
Alghamdi, Radhwan
Alkhouzaie, Moath T
ALahmari, Nawaf
Alhudaifi, Abdulrahman
Alkasih, Yaser
Elyahia, Wyle
ALghamdi, Khalid
author_sort Algamdi, Bader N
collection PubMed
description Background Isotretinoin is the most effective treatment for moderate to severe acne. However, isotretinoin has many side effects related to its use. Since 1983, when Hetzen reported the first occurrence of new depressive symptoms in patients treated with isotretinoin, a lot of controversies emerged regarding the causal relationship between isotretinoin and depression. Objective To evaluate depression among acne patients treated with isotretinoin versus doxycycline at King Fahad Hospital of the University between December 2019-March 2020. Methods Using the Global Acne Grading System, patients aged 18 - 30 years old with moderate to severe acne vulgaris who have not received isotretinoin previously and has no personal or family history of any psychiatric illnesses, were evaluated for depression using the patient health questionnaire-9 before starting treatment and 8 weeks after. Twenty-nine patients had met the inclusion criteria and were included in the study. Results Of the 29 patients included, 18 patients completed the study (nine males, nine females). Twelve patients received isotretinoin 0.5mg/kg (study group) and six patients received doxycycline 100mg (control group). The mean depression score for the isotretinoin group has decreased from (4 ± 2.48) to (3.08 ± 2.84) but the result was statistically insignificant with a p-value of 0.19, CI (-5.28, 2.36). For the doxycycline group, the mean depression score has decreased from (5.5 ± 2.5) to (2.83 ± 0.75) with a p-value of 0.043, CI (0.12, 5.21). There was no statistically significant difference in the mean depression score between the two groups after 8 weeks of starting treatment [p-valve 0.837, CI (-2.28, 2.78)]. Conclusion This study showed that, after 8 weeks of starting treatment, isotretinoin at 0.5 mg/kg has no risk of developing depression. The results of this study did not reveal a direct relationship between the use of isotretinoin and the development of depression. Furthermore, optimum control and treatment of acne vulgaris have shown to improve depression scores.
format Online
Article
Text
id pubmed-7751261
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-77512612020-12-23 Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin Algamdi, Bader N ALdahlan, Hussam W ALALhareth, Hussain Alghamdi, Radhwan Alkhouzaie, Moath T ALahmari, Nawaf Alhudaifi, Abdulrahman Alkasih, Yaser Elyahia, Wyle ALghamdi, Khalid Cureus Dermatology Background Isotretinoin is the most effective treatment for moderate to severe acne. However, isotretinoin has many side effects related to its use. Since 1983, when Hetzen reported the first occurrence of new depressive symptoms in patients treated with isotretinoin, a lot of controversies emerged regarding the causal relationship between isotretinoin and depression. Objective To evaluate depression among acne patients treated with isotretinoin versus doxycycline at King Fahad Hospital of the University between December 2019-March 2020. Methods Using the Global Acne Grading System, patients aged 18 - 30 years old with moderate to severe acne vulgaris who have not received isotretinoin previously and has no personal or family history of any psychiatric illnesses, were evaluated for depression using the patient health questionnaire-9 before starting treatment and 8 weeks after. Twenty-nine patients had met the inclusion criteria and were included in the study. Results Of the 29 patients included, 18 patients completed the study (nine males, nine females). Twelve patients received isotretinoin 0.5mg/kg (study group) and six patients received doxycycline 100mg (control group). The mean depression score for the isotretinoin group has decreased from (4 ± 2.48) to (3.08 ± 2.84) but the result was statistically insignificant with a p-value of 0.19, CI (-5.28, 2.36). For the doxycycline group, the mean depression score has decreased from (5.5 ± 2.5) to (2.83 ± 0.75) with a p-value of 0.043, CI (0.12, 5.21). There was no statistically significant difference in the mean depression score between the two groups after 8 weeks of starting treatment [p-valve 0.837, CI (-2.28, 2.78)]. Conclusion This study showed that, after 8 weeks of starting treatment, isotretinoin at 0.5 mg/kg has no risk of developing depression. The results of this study did not reveal a direct relationship between the use of isotretinoin and the development of depression. Furthermore, optimum control and treatment of acne vulgaris have shown to improve depression scores. Cureus 2020-12-17 /pmc/articles/PMC7751261/ /pubmed/33364137 http://dx.doi.org/10.7759/cureus.12126 Text en Copyright © 2020, Algamdi et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Algamdi, Bader N
ALdahlan, Hussam W
ALALhareth, Hussain
Alghamdi, Radhwan
Alkhouzaie, Moath T
ALahmari, Nawaf
Alhudaifi, Abdulrahman
Alkasih, Yaser
Elyahia, Wyle
ALghamdi, Khalid
Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
title Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
title_full Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
title_fullStr Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
title_full_unstemmed Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
title_short Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
title_sort evaluating depression among acne vulgaris patients treated with isotretinoin
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751261/
https://www.ncbi.nlm.nih.gov/pubmed/33364137
http://dx.doi.org/10.7759/cureus.12126
work_keys_str_mv AT algamdibadern evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT aldahlanhussamw evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alalharethhussain evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alghamdiradhwan evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alkhouzaiemoatht evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alahmarinawaf evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alhudaifiabdulrahman evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alkasihyaser evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT elyahiawyle evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin
AT alghamdikhalid evaluatingdepressionamongacnevulgarispatientstreatedwithisotretinoin